Show simple item record

dc.contributor.authorLin, Mei Yun
dc.date.accessioned2022-01-25T21:51:18Z
dc.date.available2022-01-25T21:51:18Z
dc.date.issued2021
dc.identifier.urihttp://hdl.handle.net/20.500.12648/7059
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectEwing Sarcomaen_US
dc.subjectMithramycin Aen_US
dc.subjectRadiosensitizeren_US
dc.subjectDNA Damage Responseen_US
dc.subjectDNA Double-strand Break Repairen_US
dc.subjectNano-formulationen_US
dc.titlePRECLINICAL EVALUATION OF MITHRAMYCIN A FOR TARGETED THERAPY OF EWING SARCOMAen_US
dc.typeDissertationen_US
refterms.dateFOA2022-01-26T21:44:56Z
dc.description.institutionUpstate Medical Universityen_US
dc.description.departmentAnatomy & Cell Biologyen_US
dc.description.degreelevelPhDen_US


Files in this item

Thumbnail
Name:
Meiyun_Thesis_Final17dec2021.pdf
Size:
39.88Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 International
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International